Cointime

Proxima Therapeutics

company

About

Proxima Therapeutics develops radiation delivery systems for the treatment of solid cancerous tumors.

  • 101 - 250

Highlights

Total Funding Amount
$31M
Funding Rounds
2
Investors
3

Details

Last Funding Type
Series E
Last Funding Money Raised
$14M
Industries
Health Care,Health Diagnostics,Medical
Founded date
Jan 1, 1996
Number Of Employee
101 - 250
Operating Status
Active

Proxima Therapeutics develops radiation delivery systems for the treatment of solid cancerous tumors, with an initial focus on brain and breast cancer.


Founded in 1996, the company’s marketed products include GliaSite RTS for brain cancer and MammoSite RTS for breast cancer. Proxima Therapeutics was acquired by Cytec Industries Inc. in 2005.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$31M
Proxima Therapeutics has raised a total of $31M in funding over 2 rounds. Their latest funding was raised on Aug 17, 2002 from a Series E round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Aug 17, 2002 Series E $14M 3 — — Detail
Feb 2, 2001 Series D $17M 1 — — Detail

Investors

Number of Lead Investors
Number of Investors
—
3
Proxima Therapeutics is funded by 3 investors. Boston Scientific and Hillman Medical Ventures are the most recent investors.
Investor Name Lead Investor Funding Round
Boston Scientific — Series E
Hillman Medical Ventures — Series E
Pilgrim Baxter Hybrid Partners — Series E
Cointime
เนื้อหา
บริษัท